Related Experiment Videos

Viral oncoprotein binding to pRB, p107, p130, and p300

J W Ludlow1, G R Skuse

  • 1Department of Biochemistry, School of Medicine and Dentistry, Rochester, NY 14642, USA.

Virus Research
|February 1, 1995
PubMed

Insights

This review highlights how DNA tumor viruses transform cells by inactivating growth-regulating proteins. This mechanism, involving tumor suppressor pathways, is crucial for understanding viral oncogenesis.

Area of Science:

  • Oncology
  • Virology
  • Molecular Biology

Background:

  • Tumor viruses are known to cause cancer through various mechanisms.
  • Oncoproteins from viruses like adenovirus, SV40, and HPV interact with key cellular proteins such as pRB and p53.
  • The role of other tumor viruses and their interaction with cellular tumor suppressors requires further attention.

Purpose of the Study:

  • To review and highlight research on DNA tumor viruses beyond the commonly studied adenovirus, SV40, and HPV.
  • To emphasize the role of viral inactivation of cellular negative regulators of cell growth.
  • To consolidate evidence supporting a common mechanism of cell transformation by DNA tumor viruses.

Main Methods:

  • Literature review of existing studies on tumor viruses and cell transformation.
  • Analysis of data concerning viral oncoprotein interactions with cellular proteins.
  • Synthesis of findings related to the inactivation of cell growth regulators.

Main Results:

  • Evidence suggests a common mechanism for cell transformation by DNA tumor viruses.
  • This mechanism involves the inactivation of cellular proteins that normally inhibit cell growth.
  • Research beyond well-known oncoproteins provides further support for this model.

Conclusions:

  • The inactivation of cellular negative regulators of cell growth is a key mechanism by which DNA tumor viruses transform cells.
  • Further research into less-studied tumor viruses can elucidate broader principles of viral oncogenesis.
  • Understanding these viral strategies is vital for developing targeted cancer therapies.

Related Concept Videos